A hereditary cancer NGS assay covering 31 selected genes with library preparation, bioinformatic analysis, and report generation.
ViennaLab Hereditary Cancer NGS Assay supports unbiased identification and annotation of coding mutations in genes associated with hereditary cancer syndromes including hereditary breast and ovarian cancer, Lynch syndrome, Li-Fraumeni syndrome, and Cowden syndrome.
Core assay points from ViennaLab's hereditary cancer page.
Combines library preparation, proprietary bioinformatic analysis, and genetic variant report generation.
Covers whole coding sequence and exon-intron boundaries of 31 hereditary cancer genes.
Supports detection of SNVs, InDels, CNVs, and MSI in the defined target regions.
Uses target enrichment by hybridization for focused hereditary oncology analysis.
Recommended for Illumina MiSeq, MiSeq i100 series, MiniSeq, and iSeq 100 instruments.
ViennaLab lists IFU and brochure support for the assay, plus support resources for library molarity and sample sheet preparation.
Instruction document is listed for REF 9-221.
Assay brochure is listed on the ViennaLab product page.
NGS support includes library molarity and sample sheet resources.
Proprietary analysis and reporting workflow support is part of the solution.
Our team can help with product selection, workflow fit, ordering details, and implementation support.